MORGAN STANLEY - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$15,799,000
-44.3%
467,442
-61.4%
0.00%
-50.0%
Q1 2021$28,340,000
-19.7%
1,211,640
-1.2%
0.00%
-20.0%
Q4 2020$35,305,000
+1067.1%
1,225,855
+720.9%
0.01%
+400.0%
Q3 2020$3,025,000
+976.5%
149,327
+1494.0%
0.00%
Q2 2020$281,000
+251.2%
9,368
+267.4%
0.00%
Q1 2020$80,000
-95.4%
2,550
-93.1%
0.00%
Q4 2019$1,741,000
+4481.6%
36,951
+534.2%
0.00%
Q3 2019$38,000
+3700.0%
5,826
+8105.6%
0.00%
Q2 2019$1,000
-97.0%
71
-97.1%
0.00%
Q1 2019$33,000
-8.3%
2,463
-72.4%
0.00%
Q4 2018$36,000
-39.0%
8,915
+1.7%
0.00%
Q3 2018$59,0008,7660.00%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q3 2021.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders